Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay.

MLA

Schnur, Sabrina, et al. “Inflammatory Bowel Disease Addressed by Caco-2 and Monocyte-Derived Macrophages: An Opportunity for an in Vitro Drug Screening Assay.” In Vitro Models, vol. 1, no. 4–5, 2022, pp. 365–83. EBSCOhost, https://doi.org/10.1007/s44164-022-00035-8.

APA

Schnur, S., Wahl, V., Metz, J. K., Gillmann, J., Hans, F., Rotermund, K., Zäh, R.-K., Brück, D. A., Schneider, M., & Hittinger, M. (2022). Inflammatory bowel disease addressed by Caco-2 and monocyte-derived macrophages: an opportunity for an in vitro drug screening assay. In Vitro Models, 1(4–5), 365–383. https://doi.org/10.1007/s44164-022-00035-8

Chicago

Schnur, Sabrina, Vanessa Wahl, Julia K Metz, Jessica Gillmann, Fabian Hans, Katharina Rotermund, Ralf-Kilian Zäh, Dietmar A Brück, Marc Schneider, and Marius Hittinger. 2022. “Inflammatory Bowel Disease Addressed by Caco-2 and Monocyte-Derived Macrophages: An Opportunity for an in Vitro Drug Screening Assay.” In Vitro Models 1 (4–5): 365–83. doi:10.1007/s44164-022-00035-8.